一个具有活动跟踪的数字平台,用于长期COVID中的能源管理支持:一个随机对照试验
Nilihan Em Sanal-Hayes1, Lawrence D Hayes2, Jacqueline L Mair3,4,5
1School of Health and Society, University of Salford, Salford, UK.
Nature communications
|February 2, 2026
概括
长期COVID (LC) 的即时能源管理应用程序干预显示对后炼不适 (PEM) 的影响很小. 未来的研究应该在具有较低自发恢复率的条件下探索这种方法,例如慢性疲劳综合征 (CFS).
科学领域:
- 康复医学 康复医学 康复医学
- 数字健康数字健康
- 慢性疾病管理 慢性疾病管理
背景情况:
- 长期COVID (LC) 经常表现为衰弱的运动后不适 (PEM),影响日常功能.
- 有效的能源管理策略对于患有LC症状的人来说至关重要.
- 目前对LC的干预往往缺乏针对能源监管的定制,实时支持.
研究的目的:
- 评估在长期COVID的成年人中进行能源管理的即时数字干预措施的有效性.
- 将"Pace Me"应用程序与可穿戴活动追踪器与标准护理对运动后不适的影响进行比较.
主要方法:
- 一个为期6个月的实用随机对照试验 (RCT) 涉及250名长期COVID的成年人.
- 干预小组收到了"Pace Me"应用程序,可穿戴的追踪器,以及用于能源管理的即时消息.
- 对照组接受了一个带有数据输入屏幕的应用程序;主要结果是通过DePaul症状问卷-PEM (DSQ-PEM) 测量PEM.
主要成果:
- 对于初级结果 (DSQ-PEM),没有观察到按组时间的显著相互作用,这表明干预的效果是微不足道的 (p=0.614, η2p=0.002).
- 干预组和对照组都显示了从基线到随访的PEM得分没有显著变化.
- 在DSQ-PEM中,没有个体症状问题表明了群体之间的显著相互作用效应.
结论:
- 在这项试验中",Pace Me"即时干预证明了在长期COVID患者中管理PEM的标准护理相比,额外的额外益处很小.
- 在LC群体中高自发康复率和广泛的纳入标准可能会混结果,可能掩盖干预效应.
- 能源管理框架要求在自然恢复较少的条件下进行进一步的研究,例如慢性疲劳综合征 (CFS).
相关概念视频
Activation Energy
86.6K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.6K
Conservation of Energy in Control Volume
1.1K
Consider a turbine operating under steady-flow conditions. The control volume is drawn around the turbine, with fluid entering at one point and exiting at another. The turbine extracts energy from the fluid, which performs mechanical work (shaft work).
For steady flow systems, the time derivative of the stored energy becomes zero since there is no energy accumulation within the control volume. This simplifies the energy equation to:
For steady flow systems, the time derivative of the stored energy becomes zero since there is no energy accumulation within the control volume. This simplifies the energy equation to:
1.1K
Bond Dissociation Energy and Activation Energy
11.1K
Bond energy is the energy required to break a bond homolytically. These values are usually expressed in units of kcal/mol or kJ/mol and are referred to as bond dissociation energies when given for specific bonds or average bond energies when indicated for a given type of bond over many compounds. Firstly, the bond dissociation energy for a single bond is weaker than that of a double bond, which in turn is weaker than that of a triple bond. Secondly, hydrogen forms relatively strong bonds with...
11.1K
Enzymes and Activation Energy
23.6K
The activation energy (or free energy of activation), abbreviated as Ea, is the small amount of energy input necessary for all chemical reactions to occur. During chemical reactions, certain chemical bonds break, and new ones form. For example, when a glucose molecule breaks down, bonds between the molecule's carbon atoms break. Since these are energy-storing bonds, they release energy when broken. However, the molecule must be somewhat contorted to get into a state that allows the bonds to...
23.6K
Self-Help Support Groups
352
Self-help support groups are voluntary, community-based organizations that provide a platform for individuals with shared concerns to exchange support, insights, and practical strategies for coping with life challenges. Typically led by group members or paraprofessionals, these groups form a cornerstone of mental health care, especially in reaching populations that are underserved by traditional healthcare systems.
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
352
Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K


